Total Payments
$92,852
2024 Payments
$47,379
Companies
63
Transactions
1,889
Medicare Patients
5,570
Medicare Billing
$473,926
Payment Breakdown by Category
Other$55,250 (59.5%)
Food & Beverage$27,757 (29.9%)
Travel$4,928 (5.3%)
Consulting$4,736 (5.1%)
Education$180.88 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $55,250 | 40 | 59.5% |
| Food and Beverage | $27,757 | 1,804 | 29.9% |
| Travel and Lodging | $4,928 | 34 | 5.3% |
| Consulting Fee | $4,736 | 2 | 5.1% |
| Education | $180.88 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $41,872 | 211 | $0 (2024) |
| Amgen Inc. | $30,395 | 233 | $0 (2024) |
| Novo Nordisk Inc | $3,327 | 279 | $0 (2024) |
| ABBVIE INC. | $1,720 | 116 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,596 | 107 | $0 (2024) |
| Abbott Laboratories | $1,312 | 91 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,249 | 79 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,092 | 79 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,052 | 82 | $0 (2024) |
| Lilly USA, LLC | $940.22 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,379 | 308 | AstraZeneca Pharmaceuticals LP ($28,809) |
| 2023 | $25,510 | 266 | Amgen Inc. ($12,539) |
| 2022 | $3,631 | 247 | Amgen Inc. ($755.32) |
| 2021 | $4,634 | 222 | AstraZeneca Pharmaceuticals LP ($1,610) |
| 2020 | $2,795 | 196 | Amgen Inc. ($330.92) |
| 2019 | $3,081 | 222 | Amgen Inc. ($510.17) |
| 2018 | $2,862 | 209 | Amgen Inc. ($406.62) |
| 2017 | $2,959 | 219 | Novo Nordisk Inc ($445.37) |
All Payment Transactions
1,889 individual payment records from CMS Open Payments — Page 1 of 76
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $54.71 | General |
| Category: Hematology | ||||||
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: PAIN | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $25.49 | General |
| Category: Endovascular | ||||||
| 12/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: Diabetes Care | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $82.41 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $197.75 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $97.89 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 894 | 1,144 | $162,176 | $73,886 |
| 2022 | 16 | 1,158 | 1,509 | $206,324 | $97,109 |
| 2021 | 22 | 1,482 | 1,945 | $249,695 | $118,582 |
| 2020 | 25 | 2,036 | 4,483 | $385,744 | $184,349 |
Total Patients
5,570
Total Services
9,081
Medicare Billing
$473,926
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 299 | 445 | $79,210 | $29,743 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 237 | 339 | $40,341 | $16,167 | 40.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $11,680 | $8,467 | 72.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 74 | 74 | $6,520 | $5,169 | 79.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $9,275 | $5,049 | 54.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 17 | $6,800 | $2,802 | 41.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $2,660 | $2,025 | 76.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 82 | $2,050 | $2,009 | 98.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 28 | 29 | $2,030 | $1,340 | 66.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 30 | 30 | $750.00 | $735.00 | 98.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $350.00 | $233.52 | 66.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 17 | $510.00 | $145.83 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 337 | 528 | $93,984 | $35,887 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 317 | 462 | $54,978 | $23,671 | 43.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 35 | 35 | $12,600 | $9,730 | 77.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $11,200 | $6,733 | 60.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 83 | 83 | $7,055 | $5,620 | 79.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 21 | 21 | $3,990 | $3,303 | 82.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 20 | 21 | $8,400 | $2,872 | 34.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 99 | 102 | $2,550 | $2,504 | 98.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 40 | 44 | $3,080 | $2,185 | 71.0% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 22 | 22 | $3,520 | $1,780 | 50.6% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 17 | 18 | $1,440 | $1,204 | 83.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 38 | 38 | $950.00 | $932.75 | 98.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $781.00 | $254.97 | 32.6% |
About Dr. Julie Detemple, MD
Dr. Julie Detemple, MD is a Family Medicine healthcare provider based in South Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376505206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julie Detemple, MD has received a total of $92,852 in payments from pharmaceutical and medical device companies, with $47,379 received in 2024. These payments were reported across 1,889 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($55,250).
As a Medicare-enrolled provider, Detemple has provided services to 5,570 Medicare beneficiaries, totaling 9,081 services with total Medicare billing of $473,926. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location South Charleston, WV
- Active Since 04/05/2006
- Last Updated 11/21/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376505206
Products in Payments
- AIRSUPRA (Drug) $34,613
- Repatha (Biological) $27,742
- FARXIGA (Drug) $1,319
- Ozempic (Drug) $1,257
- XARELTO (Drug) $1,119
- JARDIANCE (Drug) $876.74
- EVENITY (Biological) $722.58
- UBRELVY (Drug) $714.22
- Aimovig (Biological) $694.05
- Rybelsus (Drug) $641.80
- NURTEC ODT (Drug) $601.21
- XIFAXAN (Drug) $575.02
- Otezla (Drug) $547.24
- TRADJENTA (Drug) $492.43
- Vascepa (Drug) $485.12
- TOUJEO (Drug) $439.32
- Victoza (Drug) $416.71
- FREESTYLE LIBRE 3 (Device) $416.29
- SHINGRIX (Biological) $415.63
- QULIPTA (Drug) $411.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Charleston
Dr. Rohit Patel, M.d, M.D
Family Medicine — Payments: $26,815
Family Medicine $26,815
Joshua Bradford, Do, DO
Family Medicine — Payments: $18,789
Family Medicine $18,789
Michelle Burdette, Md, Retired, MD, RETIRED
Family Medicine — Payments: $12,269
Family Medicine $12,269
Dr. Chad Turner, Md, MD
Family Medicine — Payments: $10,522
Family Medicine $10,522
Dr. John Frame, D.o, D.O
Family Medicine — Payments: $8,656
Family Medicine $8,656
Howard Lafferty, Do, DO
Family Medicine — Payments: $7,233
Family Medicine $7,233